Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

Ulrich A Walker, Veronika K Jaeger, Katerina Chatzidionysiou, Merete L Hetland, Ellen-Margrethe Hauge, Karel Pavelka, Dan C Nordström, Helena Canhão, Matija Tomšič, Ronald van Vollenhoven, Cem Gabay

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences